Crookes Healthcare has revised the summary of product characteristics for its product Curatoderm (tacalcitol monohydrate) 4µg/g ointment. Curatoderm can now be used for scalp psoriasis. The maximum daily dose has been increased to 10g daily. There is now clinical trial experience with continuous and intermittent treatment in adults for up to 12 months.